超级碰在线-超级碰碰永久免费视频播放-超级碰碰碰免费视频播放-超级碰碰碰免费视频-亚洲国产99在线精品一区69堂-亚洲高清资源在线观看

瑞典CellaVision
CellaVision AB 開發、營銷并銷售市場領先的用于血液和其他體液常規分析的圖像分析系統。公司在開發用于健康和醫療護理的細胞和細胞變化的自動圖像分析的軟硬件領域具有核心競爭力。它開發并營銷白細胞和紅細胞的自動分類系統，以及分類的教學和質量保證軟件。公司的合作者擁有高級圖像分析、人工智能和自動顯微鏡學的專業技術。

公司總部位于瑞典的隆德（Lund），在美國佛羅里達，加拿大多倫多和日本的橫濱都有分支機構。

CellaVision AB develops and markets products for the health care sector, enabling fast and firm blood cell analysis and quality assurance of morphology diagnosis.

The company has cutting-edge expertise within sophisticated digital image analysis, artificial intelligence and automated microscopy. For laboratories, this means increased efficiency, a simplification of the procedures and confirmed proficiency.
 

The product line includes systems for automatic blood cell differentials and software for differential proficiency testing and education. The products are sold to hospital laboratories and independent commercial laboratories. Today CellaVision is represented in Europe, the U.S. and to some extent in Asia.

Vision
To create a global de facto standard for digital microscopy analysis and thereby contribute to improved care quality and cost efficient medical care

Background
Based in Lund, Sweden, CellaVision was founded in 1994. The CellaVision concept of automated microscopy analysis comes from Christer F?hraeus and engineers connected to Lund Institute of Technology and the Ideon Science Park. Since 2001, the company also has a U.S. subsidiary in Jupiter, Fl, USA. In January 2007, a subsidiary in Toronto, ON, Canada was established, and one year later a subsidiary in Yokohama, Japan.

Owners
CellaVision has about 700 shareholders who have provided capital in connection with new stock issues. The principal owner is H&B Capital LP. Other major shareholders are Stiftelsen Industrifonden, Metallica F?rvaltnings AB, Christer F?hraeus, Life Equity Sweden KB and SIF.